000			02071 a2200625 4500
005			20250516032555.0
264		0	_c20110809
008			201108s 0 0 eng d
022			_a1600-0609
024	7		_a10.1111/j.1600-0609.2011.01602.x _2doi
040			_aNLM _beng _cNLM
100	1		_aZangari, Maurizio
245	0	0	_aAlkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients. _h[electronic resource]
260			_bEuropean journal of haematology _cJun 2011
300			_a484-7 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article
650	0	4	_aAlkaline Phosphatase _xblood
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBoronic Acids _xtherapeutic use
650	0	4	_aBortezomib
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aOligopeptides _xtherapeutic use
650	0	4	_aOsteogenesis _xdrug effects
650	0	4	_aProtease Inhibitors _xtherapeutic use
650	0	4	_aProteasome Inhibitors
650	0	4	_aPyrazines _xtherapeutic use
650	0	4	_aRetrospective Studies
650	0	4	_aTreatment Outcome
700	1		_aAujay, Monette
700	1		_aZhan, Fenghuang
700	1		_aHetherington, Kristina L
700	1		_aBerno, Tamara
700	1		_aVij, Ravi
700	1		_aJagannath, Sundar
700	1		_aSiegel, David
700	1		_aKeith Stewart, A
700	1		_aWang, Luhua
700	1		_aOrlowski, Robert Z
700	1		_aBelch, Andrew
700	1		_aJakubowiak, Andrzej
700	1		_aSomlo, George
700	1		_aTrudel, Suzanne
700	1		_aBahlis, Nizar
700	1		_aLonial, Sagar
700	1		_aSinghal, Seema
700	1		_aKukreti, Vishal
700	1		_aTricot, Guido
773	0		_tEuropean journal of haematology _gvol. 86 _gno. 6 _gp. 484-7
856	4	0	_uhttps://doi.org/10.1111/j.1600-0609.2011.01602.x _zAvailable from publisher's website
999			_c20744105 _d20744105